Chemical and Pharmaceutical Bulletin
The Pharmaceutical Society of Japan, established in 1880, is one of Japan’s oldest and most distinguished academic societies. The Society currently has around 15,000 members. It publishes three monthly scientific journals. Chemical and Pharmaceutical Bulletin (Chem. Pharm. Bull.) began publication in 1953 as Pharmaceutical Bulletin. It covers chemistry fields in the pharmaceutical and health sciences. Biological and Pharmaceutical Bulletin (Biol. Pharm. Bull.) began publication in 1978 as the Journal of Pharmacobio-Dynamics, which then merged the Journal of Health Science, another former Society’s journal, in 2012. It covers various biological topics in the pharmaceutical and health sciences. Yakugaku Zasshi (Japanese for “Pharmaceutical Science Journal”) has the longest history, with publication beginning in 1881. Yakugaku Zasshi is published mostly in Japanese, except for some articles related to clinical pharmacy and pharmaceutical education, which are published in English. The main aim of the Society’s journals is to advance the pharmaceutical sciences with research reports, scientific communication, and high-quality discussion. The average review time for articles submitted to the journals is around one month for first decision. The complete texts of all of the Society’s journals can be freely accessed through J-STAGE. The Society’s editorial committee hopes that the content of its journals will be useful to your research, and also invites you to submit your own work to the journals.

Chairman of Committee
Hidehiko Nakagawa
Graduate School of Pharmaceutical Sciences, Nagoya City University

Read more
28,312 registered articles
(updated on October 24, 2024)
Online ISSN : 1347-5223
Print ISSN : 0009-2363
ISSN-L : 0009-2363
1.5
2023 Journal Impact Factor (JIF)
JOURNAL PEER REVIEWED FREE ACCESS FULL-TEXT HTML ADVANCE PUBLICATION
Scopus Pubmed
Featured article
Volume 72 (2024) Issue 9 Pages 794-799
Development of Drug Discovery Platforms Using Artificial Intelligence and Cheminformatics Read more
Editor's pick

Productivity in drug discovery is expected to increase through greater use of in silico technology. The authors have developed AI models applicable to a variety of drug discovery tasks, including molecular design, activity prediction and side-effect profiling. The characteristics of training data in the context of drug discovery are also discussed, providing insights for future AI development. The authors also perform wet experiments in addition to dry research. They present examples of using in silico technology for drug discovery, including developing pharmacokinetic enhancers and drug design against multidrug-resistant bacteria.

Volume 72 (2024) Issue 9 Pages 800-803
Effect of Noise Filtering in an Ultraviolet Detector of UHPLC on the Statistical Reliability of Chemometrically Evaluated Repeatability Read more
Editor's pick

Repeatability is a significant parameter, expressed as the relative standard deviation (RSD) of measured values, applied to validate the performance of a UHPLC system.  The authors proposed a chemometric tool to estimate the RSD of the peak area obtained from the UHPLC equipped with a noise filter, and the RSDs estimated by this tool were demonstrated to be more reliable than those by 50 repetitive measurements.  Using the chemometric tool, the resources needed to evaluate repeatability can be reduced, and thus the efficiency of repeatability evaluation will be remarkably improved in a UHPLC analysis.

Volume 72 (2024) Issue 9 Pages 810-816
Development of a Fluorescence Probe for Detecting Nitroreductase Activity Based on Steric Repulsion-Induced Twisted Intramolecular Charge Transfer (sr-TICT) Read more
Editor's pick

This report described the usefulness of the design strategy for fluorescence probes that controls intramolecular steric repulsion, previously reported by the authors, i.e., the steric repulsion-induced twisted intramolecular charge transfer (sr-TICT) mechanism. To demonstrate the utility of this strategy, the authors describe an application of quinone methide chemistry, which is widely used as a fluorescence off/on switching reaction in fluorescence probes for enzymatic activity detection, to construct a fluorescence probe targeting nitroreductase (NTR) activity. This research suggests that the sr-TICT mechanism would be useful for the development of fluorescence probes for a variety of enzymes.

Volume 72 (2024) Issue 9 Pages 826-830
Synthesis and Cytotoxicity of Cyclic Octapeptide Surugamides with Varied N-Acyl Moieties Read more
Editor's pick

Surugamides are cyclic octapeptides originally isolated from Streptomyces as cathepsin B inhibitors. Subsequent studies have shown that derivatives featuring an acyl group on the e-amino group of the lysine residue exhibit higher activity compared to non-acylated surugamides in cell-based or whole-organism assays. This study evaluated the cytotoxicity profiles of four synthetic acyl surugamides, revealing that larger hydrophobic acyl groups on the lysine e-amino group enhance cytotoxicity. It also identified new derivatives with sub-micromolar potencies and demonstrated that the appropriate size of the acyl substituent is crucial for activity.

Volume 72 (2024) Issue 9 Pages 831-837
Structure Derivatization of IgG-Binding Peptides and Analysis of Their Secondary Structure by Circular Dichroism Spectroscopy Read more
Editor's pick

[Highlighted Paper selected by Editor-in-Chief]
Affinity peptides that target the fragment crystallizable (Fc) region of IgG (IgG-binding peptides) are widely employed in pharmaceutical applications. The authors conducted structural derivatization of an IgG-binding peptide – specifically, a hairpin-like cyclic peptide featuring a twisted beta-strand – and evaluated the effect of its secondary structure on IgG-binding activity using circular dichroism (CD) spectroscopy. Through the integration of both current and previous findings, four potent IgG-binding affinity peptides were identified. This research has significant potential for the application of IgG-binding peptides, particularly in the development of homogeneously modified antibody-drug conjugates (ADCs).

View all featured articles
View all articles in current issue
Most viewed articles (September 2024)
Share this page
Browse by volume and issue
Announcements from publisher
  • Chem. Pharm. Bull. Vol. 72 No. 9
    Current Topics: Recent Advances in Artificial Intelligence and in Silico Technologies for Academic Drug Discovery
  • Chem. Pharm. Bull. Vol. 72 No. 7
    Current Topics: Frontiers in Alzheimer's and Dementia Research
  • Chem. Pharm. Bull. Vol. 72 No. 3
    Current Topics: Progress in Electrochemical Analysis for the Pharmaceutical Sciences
  • Chem. Pharm. Bull. Vol. 72 No. 2
    Current Topics: Advanced Medicinal Chemistry in Academia
  • Announcement of Academic Journals’ Awards Chemical and Pharmaceutical Bulletin (CPB) https://cpb.pharm.or.jp/award/cpb_award.pdf
feedback
Top